Dr. Lydia Usha, MD

Dr. Usha practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Usha's NPI, 1336109693, was assigned on March 23, 2006. Dr. Usha holds Illinois license 036-096422.

Dr. Usha's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Usha's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Usha is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Medical Center. Dmand AI also links Dr. Usha to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account. Dr. Usha's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Usha practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Usha's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Usha is licensed in Illinois.

Dmand AI lists breast cancer and chronic anemia among the conditions Dr. Usha treats.

CMS data shows 300 Medicare services from Dr. Usha across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $20,289 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Usha in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 75% have high blood pressure. 41% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Usha's median patient age at 70, with 99% women.

In 2024, Dr. Usha wrote 796 Medicare Part D claims for 175 patients. 80% of them were for generic drugs. CMS names the drug for 660 of them, across 12 drugs with 11 or more claims each, at $1,163,336 in total drug cost. In 2023, CMS named 808 claims across 12 drugs.

Dr. Usha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Usha as offering telehealth.

Dmand AI links 35 papers to Dr. Usha, published from 2008 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Ovarian Neoplasms and Biopsy. Dr. Usha has published most often in J Natl Compr Canc Netw. Dr. Usha's most frequent co-authors are Melody A. Cobleigh, MD, Timothy M. Kuzel, MD and Ruta D. Rao, MD.

Dmand AI links Dr. Usha to 2 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Ovarian Epithelial, Triple Negative Breast Neoplasms and Breast Neoplasms.

CMS Open Payments shows 31 general payments to Dr. Usha from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. AstraZeneca Pharmaceuticals LP paid the most, $7,004. It also lists 1 research payment totaling $45 in 2016.

Dmand AI lists 1 award for Dr. Usha, most recently CMS Stage 1 EHR in 2013.

Dr. Usha is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.